As at Feb 25, 2025, the OSCR stock has a price-to-earnings ratio of 141.91. This is based on the current EPS of $0.11 and the stock price of $15.61 per share.
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 122.18 | N/A | $13.44 | $0.11 |
2023 | N/A | N/A | $9.15 | -$1.22 |
2022 | N/A | N/A | $2.46 | -$2.85 |
2021 | N/A | N/A | $7.85 | -$3.2 |
2020 | N/A | N/A | N/A | -$14.16 |
2019 | N/A | N/A | N/A | -$9.06 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 122.18 | -30.87% | $13.44 | $0.11 |
Sep 2024 | 176.75 | -44.14% | $21.21 | $0.12 |
Jun 2024 | 316.4 | N/A | $15.82 | $0.05 |
Mar 2024 | N/A | N/A | $14.87 | -$0.26 |
Dec 2023 | N/A | N/A | $9.15 | -$1.22 |
Sep 2023 | N/A | N/A | $5.57 | -$1.59 |
Jun 2023 | N/A | N/A | $8.06 | -$2.21 |
Mar 2023 | N/A | N/A | $6.54 | -$2.67 |
Dec 2022 | N/A | N/A | $2.46 | -$2.85 |
Sep 2022 | N/A | N/A | $4.99 | -$2.78 |
Jun 2022 | N/A | N/A | $4.25 | -$2.89 |
Mar 2022 | N/A | N/A | $9.97 | -$2.71 |
Dec 2021 | N/A | N/A | $7.85 | -$3.2 |
Sep 2021 | N/A | N/A | $17.39 | -$9.03 |
Jun 2021 | N/A | N/A | $21.5 | -$10.73 |
OSCR's PE ratio is higher than its peer stock PFG.
Stock name | PE ratio | Market cap |
---|---|---|
PFG Principal Financial Group Inc | 12.71 | $19.41B |
OSCR Oscar Health Inc | 141.64 | $3.9B |
LIFW MSP Recovery Inc | N/A | $14.31M |
NEUE NeueHealth Inc. | N/A | $60.64M |
The price to earnings ratio for OSCR stock is 141.91 as of Feb 25, 2025.
OSCR's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (Feb 25, 2025), Oscar Health's stock price is $15.61. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.11. Therefore, Oscar Health's P/E ratio for today is 141.91. PE RATIO(141.91) = STOCK PRICE($15.61) / TTM EPS($0.11)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.